REQUEST A DEMO
Total
USD $0.00
Search more companies

Nemuno Vaistine UAB (Lithuania)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Health and Personal Care Stores
Full name: Nemuno Vaistine UAB Profile Updated: July 03, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Russian Download a sample report

Nemuno Vaistine UAB is based in Lithuania. The head office is in Kaunas. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was incorporated on August 15, 1996. It currently has a total number of 201 - 500 (2021) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 1.9% in 2020. During that time, Nemuno Vaistine UAB’s total assets decreased by 10.96%. In 2020, Nemuno Vaistine UAB’s net profit margin decreased by 1.39%.

Headquarters
Kaunas, Taikos pr. 104D
Kaunas; Kaunas County;

Contact Details: Purchase the Nemuno Vaistine UAB report to view the information.

Website: http://www.camelia.lt

Basic Information
Total Employees:
Purchase the Nemuno Vaistine UAB report to view the information.
Outstanding Shares:
Purchase the Nemuno Vaistine UAB report to view the information.
Registered Capital:
Purchase the Nemuno Vaistine UAB report to view the information.
Incorporation Date:
August 15, 1996
Key Executives
Purchase this report to view the information.
Director
Subsidiaries
Ingen Pharma SIA (Latvia)
Company Performance
Financial values in the chart are available after Nemuno Vaistine UAB report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
1.9%
Total operating revenue
1.94%
Operating profit (EBIT)
-23.19%
Net Profit (Loss) for the Period
-24.93%
Total assets
-10.96%
Total equity
-12.12%
Operating Profit Margin (ROS)
-1.58%
Net Profit Margin
-1.39%
Return on Equity (ROE)
-8.4%
Quick Ratio
-0.01%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?